Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 2

Status

Completed 4Terminated 1Recruiting 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6Gastrointestinal 2

Conditions

Neoplasms 8Breast Neoplasms 6Malnutrition 5Stomach Neoplasms 4Head and Neck Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Prostatic Neoplasms 2Lymphoma 2Locally Advanced Head and Neck Carcinoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Cachexia 2Biliary Tract Neoplasms 2Wilms Tumor 1Surgery--Complications 1Sarcoma 1Prostatic Intraepithelial Neoplasia 1Peripheral Nervous System Diseases 1Peptic Ulcer 1Osteoporosis 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Dietary Supplements × Clear all
NCT07199556 2025-10-03

DOLFLEX

Arafarma Group, S.A.

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

NCT07021378 2025-06-15

NESTLE

D'Or Institute for Research and Education

Phase NA Completed
16 enrolled
BreastGastrointestinal

Anus Neoplasms, Breast Neoplasms, Malnutrition

NCT06214598 2024-05-09

AID

University of Belgrade

Phase NA Recruiting
90 enrolled
Breast

Breast Neoplasms

NCT05762042 2023-03-09

Comparison of the Efficacy and Tolerability of Femal Versus Placebo

Azienda Ospedaliera Ordine Mauriziano di Torino

Phase NA Completed
34 enrolled
Breast

Breast Neoplasms

NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

NCT01548534 2015-07-29

DHALYA

University Hospital, Tours

Phase 3 Terminated
65 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡